0000899243-22-001376.txt : 20220107 0000899243-22-001376.hdr.sgml : 20220107 20220107170746 ACCESSION NUMBER: 0000899243-22-001376 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220105 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VINK PATRICK V.J.J. CENTRAL INDEX KEY: 0001557501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38266 FILM NUMBER: 22518869 MAIL ADDRESS: STREET 1: ETZELSTRASSE 20 CITY: 8707 UETIKON AM SEE STATE: V8 ZIP: V8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spero Therapeutics, Inc. CENTRAL INDEX KEY: 0001701108 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 MASSACHUSETTS AVENUE STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-242-1600 MAIL ADDRESS: STREET 1: 675 MASSACHUSETTS AVENUE STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Spero Therapeutics, LLC DATE OF NAME CHANGE: 20170316 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-05 0 0001701108 Spero Therapeutics, Inc. SPRO 0001557501 VINK PATRICK V.J.J. C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 13.19 2022-01-05 4 A 0 2214 9.03 A 2032-01-05 Common Stock 2214 2214 D This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director. This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $20,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy. Exhibit 24.1 - Power of Attorney /s/ Tamara Joseph, Attorney-in-Fact for Patrick V.J.J. Vink 2022-01-07 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

                               POWER OF ATTORNEY

     Know all by these present, that the undersigned hereby constitutes and
appoints each of Satyavrat Shukla, Tamara Joseph, and Meghan Small of Spero
Therapeutics, Inc. (the "Company"), and Mathew J. Gardella and Matthew W.
Tikonoff of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., signing singly,
with full power of substitution, the undersigned's true and lawful attorney-in-
fact to: (1)	execute for and on behalf of the undersigned, forms and
authentication documents for EDGAR Filing Access;

     (2)   do and perform any and all acts for and on behalf of the undersigned
           which may be necessary or desirable to complete and execute any such
           forms and authentication documents;

     (3)   execute for and on behalf of the undersigned, in the undersigned's
           capacity as an officer, director and/or 10% shareholder of the
           Company, Forms 3, 4, and 5 in accordance with Section 16(a) of the
           Securities and Exchange Act of 1934 and the rules thereunder;

     (4)   do and perform any and all acts for and on behalf of the undersigned
           which may be necessary or desirable to complete and execute any such
           Form 3, 4, or 5 and timely file such form with the United States
           Securities and Exchange Commission and any stock exchange or similar
           authority; and

     (5)   take any other action of any type whatsoever in connection with the
           foregoing which, in the option of such attorney-in-fact, may be of
           benefit to, in the best interests of, or legally required by the
           undersigned, it being understood that the documents executed by such
           attorney-in-fact on behalf of the undersigned pursuant to this Power
           of Attorney shall be in such form and shall contain such terms and
           conditions as such attorney-in-fact may approve in such attorney-in-
           fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holding of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed on this 7th day of January, 2022.

                                        /s/ Patrick Vink
                                        ------------------------------------

                                        Patrick Vink